Merck & Co. MRK Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $18.26B+6.6% | $17.13B— | —— | $14.53B+11.3% | ||
| $820M+7.8% | $761M+18.0% | $645M+19.2% | $541M+12.9% | ||
| -$1.67B-33.8% | -$1.25B+34.2% | -$1.9B-21.1% | -$1.57B-934% | ||
| $1.09B+347% | $244M-78.7% | $1.15B+78.3% | $644M-68.3% | ||
| $1.18B+41.3% | $835M+2.3% | $816M+407% | $161M-76.1% | ||
| $110M-39.6% | $182M+148% | -$380M-31.5% | -$289M-171% | ||
| -$1.84B+20.9% | -$2.33B-231% | $1.78B+3,666% | -$50M-118% | ||
| $195M+498% | -$49M-111% | $456M+184% | -$545M-213% | ||
| $137M-86.6% | $1.02B+378% | $214M-43.7% | $380M+170% | ||
| $16.47B-23.3% | $21.47B+65.1% | $13.01B-31.9% | $19.1B+45.5% | ||
| $4.11B+21.9% | $3.37B-12.7% | $3.86B-12.0% | $4.39B-1.3% | ||
| $10.04B— | $0— | $0— | $0-100% | ||
| —— | $519M-45.7% | $955M— | —— | ||
| -$13.74B-77.7% | -$7.73B+45.3% | -$14.14B-185% | -$4.96B+69.8% | ||
| $8.18B+4.3% | $7.84B+5.3% | $7.45B+6.2% | $7.01B+6.1% | ||
| $5.08B+289% | $1.31B-3.0% | $1.35B— | $0-100% | ||
| $2.5B— | —— | $1.76B-22.0% | $2.25B— | ||
| $92M-48.0% | $177M+41.6% | $125M-67.4% | $384M+90.1% | ||
| —— | —— | -$4.81B+47.3% | -$9.12B— | ||
| $563M+292% | -$293M-1,374% | $23M— | —— | ||
| —— | —— | —— | $4.61B— | ||
| -$562M— | —— | -$355M+72.7% | -$1.3B-61.6% | ||
| $2.79B+16.6% | $2.4B+17.2% | $2.04B-2.0% | $2.09B+27.4% | ||
| $3.05B+44.7% | $2.1B+15.1% | $1.83B+0.2% | $1.82B+15.6% | ||
| —— | —— | $342M+124% | -$1.42B-173% | ||
| $110M-39.6% | $182M+148% | -$380M-31.5% | -$289M-171% | ||
| —— | —— | —— | —— | ||
| -$562M— | —— | -$355M+72.7% | -$1.3B-61.6% | ||
| $0-100% | $3.46B— | —— | $0-100% | ||
| $63M— | —— | $36M-59.6% | $89M-2.2% | ||
| $0— | $0-100% | $1.15B— | $0— | ||
| $0— | $0-100% | $1.15B— | $0— | ||
| —— | -$372M-13.4% | -$328M— | —— | ||
| —— | —— | —— | $0+100% | ||
| $12.36B-31.7% | $18.1B+83.0% | $9.89B-32.8% | $14.71B+69.6% | ||
| $12.36B-31.7% | $18.1B+83.0% | $9.89B-32.8% | $14.71B+69.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Merck & Co. generate?
- Merck & Co. (MRK) generated $17.9B in operating cash flow over the trailing twelve months.
- What is Merck & Co.'s free cash flow?
- After $3.8B of capital expenditures, Merck & Co.'s free cash flow was $14.1B over the trailing twelve months, down 17.2% year over year.
- Where does Merck & Co.'s cash flow data come from?
- Every line is extracted from Merck & Co.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
